BTDR vs. EBS

Last updated Apr 1, 2026

Compare and contrast key facts about Bitdeer Technologies Group Class A Ordinary Shares (BTDR) and Emergent BioSolutions Inc. (EBS).

Performance

BTDR vs. EBS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bitdeer Technologies Group Class A Ordinary Shares (BTDR) and Emergent BioSolutions Inc. (EBS). The values are adjusted to include any dividend payments, if applicable.

BTDR vs. EBS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
BTDR Bitdeer Technologies Group Class A Ordinary Shares	-22.84%	-48.27%	119.78%	-1.40%
EBS Emergent BioSolutions Inc.	-32.85%	29.29%	298.33%	-80.98%

Fundamentals

Market Cap BTDR : $2.32B EBS : $470.61M
EPS BTDR : $0.29 EBS : $0.94
PE Ratio BTDR : 29.48 EBS : 8.80
PS Ratio BTDR : 3.12 EBS : 0.62
PB Ratio BTDR : 2.67 EBS : 0.90
Total Revenue (TTM) BTDR : $620.25M EBS : $742.90M
Gross Profit (TTM) BTDR : $60.99M EBS : $0.00
EBITDA (TTM) BTDR : -$223.07M EBS : $271.60M

Returns By Period

In the year-to-date period, BTDR achieves a -22.84% return, which is significantly higher than EBS's -32.85% return.

BTDR

• 1D: 9.77%
• 1M: 12.34%
• YTD: -22.84%
• 6M: -49.39%
• 1Y: -2.04%
• 3Y*: —
• 5Y*: —
• 10Y*: —

EBS

• 1D: 3.11%
• 1M: 1.84%
• YTD: -32.85%
• 6M: -5.90%
• 1Y: 70.78%
• 3Y*: -7.12%
• 5Y*: -36.51%
• 10Y*: -13.28%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BTDR vs. EBS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BTDR

BTDR Risk / Return Rank: 43
BTDR Sharpe Ratio Rank: 41
BTDR Sortino Ratio Rank: 49
BTDR Omega Ratio Rank: 47
BTDR Calmar Ratio Rank: 40
BTDR Martin Ratio Rank: 39

EBS

EBS Risk / Return Rank: 74
EBS Sharpe Ratio Rank: 68
EBS Sortino Ratio Rank: 76
EBS Omega Ratio Rank: 76
EBS Calmar Ratio Rank: 75
EBS Martin Ratio Rank: 76

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BTDR vs. EBS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bitdeer Technologies Group Class A Ordinary Shares (BTDR) and Emergent BioSolutions Inc. (EBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BTDR	EBS	Difference
Sharpe ratio Return per unit of total volatility	-0.02	0.76	-0.78
Sortino ratio Return per unit of downside risk	0.75	1.87	-1.12
Omega ratio Gain probability vs. loss probability	1.09	1.25	-0.16
Calmar ratio Return relative to maximum drawdown	-0.07	1.82	-1.89
Martin ratio Return relative to average drawdown	-0.14	4.66	-4.80
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BTDR vs. EBS - Sharpe Ratio Comparison

The current BTDR Sharpe Ratio is -0.02, which is lower than the EBS Sharpe Ratio of 0.76. The chart below compares the historical Sharpe Ratios of BTDR and EBS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BTDR	EBS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.02	0.76	-0.78
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.36	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.17	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.04	-0.02	-0.02

Correlation

The correlation between BTDR and EBS is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BTDR vs. EBS - Dividend Comparison

Neither BTDR nor EBS has paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
BTDR Bitdeer Technologies Group Class A Ordinary Shares	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBS Emergent BioSolutions Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	5.65%

Drawdowns

BTDR vs. EBS - Drawdown Comparison

The maximum BTDR drawdown since its inception was -79.52%, smaller than the maximum EBS drawdown of -98.89%. Use the drawdown chart below to compare losses from any high point for BTDR and EBS.

Drawdown Indicators

	BTDR	EBS	Difference
Max Drawdown Largest peak-to-trough decline	-79.52%	-98.89%	+19.37%
Max Drawdown (1Y) Largest decline over 1 year	-71.89%	-42.95%	-28.94%
Max Drawdown (5Y) Largest decline over 5 years	—	-98.14%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-98.89%	—
Current Drawdown Current decline from peak	-66.86%	-93.85%	+26.99%
Average Drawdown Average peak-to-trough decline	-43.41%	-40.59%	-2.82%
Ulcer Index Depth and duration of drawdowns from previous peaks	37.83%	16.76%	+21.07%

Volatility

BTDR vs. EBS - Volatility Comparison

Bitdeer Technologies Group Class A Ordinary Shares (BTDR) has a higher volatility of 26.27% compared to Emergent BioSolutions Inc. (EBS) at 8.97%. This indicates that BTDR's price experiences larger fluctuations and is considered to be riskier than EBS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BTDR	EBS	Difference
Volatility (1M) Calculated over the trailing 1-month period	26.27%	8.97%	+17.30%
Volatility (6M) Calculated over the trailing 6-month period	78.31%	61.34%	+16.97%
Volatility (1Y) Calculated over the trailing 1-year period	103.71%	93.49%	+10.22%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	124.03%	102.25%	+21.78%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	124.03%	79.70%	+44.33%

Financials